ReviewFrontiers in immunology2026
Redox signaling fidelity in immunosenescence and inflammaging: from oxidative stress to precision immune geroscience.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Immunosenescence and inflammaging are accompanied by chronic inflammatory tone, impaired host-defense responses, defective resolution, and altered immunometabolic adaptation. Although these processes are often linked to oxidative stress, reactive oxygen species (ROS) also function as regulated immune signals. Here, we propose that aging immunity may involve not only increased oxidant burden but also a progressive loss of redox signaling fidelity, defined as the capacity of immune cells and tissues to generate, encode, transmit, decode, and resolve redox-dependent information with source specificity, spatially organized routing, temporal precision, biochemical reversibility, and proportionate downstream interpretation. We organize this framework into five information-flow layers: source-controlled reactive-species generation, reversible cysteine-centered and secondary-mediator encoding, spatially organized transmission, immune and inflammatory decoding, and resolution/reset by antioxidant, autophagy, mitophagy, lysosomal, and proteostatic systems. We then map age-associated fidelity loss onto T cells, B cells and hematopoietic progenitors, macrophages and microglia, neutrophils, dendritic cells, natural killer cells, regulatory T cells, and senescent-cell communication. The framework helps explain why related redox signals can support host defense, antigen-specific activation, and adaptive stress responses in one context, yet promote maladaptive NF-kappaB, NLRP3, cGAS-STING, interferon-linked inflammation, and senescence-associated secretory propagation when source coupling, timing, spatial routing, reversibility, decoder proportionality, or resolution fails. We also discuss why broad antioxidant suppression may underperform when it lowers oxidant abundance while flattening adaptive redox dynamics. Finally, we outline quantitative metrics, decisive experiments, controversies, and biomarker-guided therapeutic principles for precision immune geroscience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.